Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Solesence (SLSN) Net Income towards Common Stockholders: 2010-2025

Historic Net Income towards Common Stockholders for Solesence (SLSN) over the last 16 years, with Sep 2025 value amounting to -$1.1 million.

  • Solesence's Net Income towards Common Stockholders fell 136.78% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 36.90%. This contributed to the annual value of $4.2 million for FY2024, which is 196.47% up from last year.
  • Per Solesence's latest filing, its Net Income towards Common Stockholders stood at -$1.1 million for Q3 2025, which was down 136.64% from $3.1 million recorded in Q2 2025.
  • In the past 5 years, Solesence's Net Income towards Common Stockholders ranged from a high of $3.1 million in Q2 2025 and a low of -$2.1 million during Q4 2023.
  • Over the past 3 years, Solesence's median Net Income towards Common Stockholders value was $80,000 (recorded in 2025), while the average stood at $190,545.
  • In the last 5 years, Solesence's Net Income towards Common Stockholders soared by 884.43% in 2021 and then crashed by 1,969.35% in 2023.
  • Quarterly analysis of 5 years shows Solesence's Net Income towards Common Stockholders stood at -$357,000 in 2021, then plummeted by 460.78% to -$2.0 million in 2022, then decreased by 5.99% to -$2.1 million in 2023, then spiked by 84.40% to -$331,000 in 2024, then tumbled by 136.78% to -$1.1 million in 2025.
  • Its Net Income towards Common Stockholders was -$1.1 million in Q3 2025, compared to $3.1 million in Q2 2025 and $80,000 in Q1 2025.